133 related articles for article (PubMed ID: 25444286)
1. Conservative management of medication-related osteonecrosis of the maxilla with an obturator prosthesis.
Troeltzsch M; Probst F; Troeltzsch M; Ehrenfeld M; Otto S
J Prosthet Dent; 2015 Mar; 113(3):236-41. PubMed ID: 25444286
[TBL] [Abstract][Full Text] [Related]
2. New uses for rehabilitation protocol for oral sinus communications in ARONJ patients.
de Almeida FC; Moreira MS; Marcucci M; Marques MM; de Araujo ME; da Silva DP
J Prosthodont; 2014 Dec; 23(8):649-53. PubMed ID: 24954080
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
[TBL] [Abstract][Full Text] [Related]
5. Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Mast G; Otto S; Mücke T; Schreyer C; Bissinger O; Kolk A; Wolff KD; Ehrenfeld M; Stürzenbaum SR; Pautke C
J Craniomaxillofac Surg; 2012 Oct; 40(7):568-71. PubMed ID: 22118926
[TBL] [Abstract][Full Text] [Related]
6. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Gallego L; Junquera L
Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
[TBL] [Abstract][Full Text] [Related]
7. Prosthetic rehabilitation of acquired maxillary defects secondary to mucormycosis: clinical cases.
Shah RJ; Katyayan MK; Katyayan PA; Chauhan V
J Contemp Dent Pract; 2014 Mar; 15(2):242-9. PubMed ID: 25095851
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
Del Conte A; Bernardeschi P; La Ferla F; Turrisi G; D'Alessandro M; Montagnani F; Fiorentini G
J Oral Maxillofac Surg; 2010 May; 68(5):1179-82. PubMed ID: 20185222
[No Abstract] [Full Text] [Related]
9. Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Hewson I; Syme D; Bruscino-Raiola F
Aust Dent J; 2012 Jun; 57(2):227-30. PubMed ID: 22624766
[TBL] [Abstract][Full Text] [Related]
10. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of bisphosphonate-related osteonecrosis of the jaw: report of three cases.
Al-Zoman KH; AlBazie S; Robert AA; Baskaradoss JK; Alsuwyed AS; Ciancio S; Al-Mubarak S
J Palliat Care; 2013; 29(1):52-7. PubMed ID: 23614172
[No Abstract] [Full Text] [Related]
13. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.
Pautke C; Bauer F; Otto S; Tischer T; Steiner T; Weitz J; Kreutzer K; Hohlweg-Majert B; Wolff KD; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum SR; Kolk A
J Oral Maxillofac Surg; 2011 Jan; 69(1):84-91. PubMed ID: 20971542
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
Pechalova P; Bakardjiev A; Zaprianov Z; Vladimirov B; Poriazova E; Zheleva A; Hadjigeorgiev G; Goranova-Marinova V; Goranov S
Acta Clin Croat; 2011 Jun; 50(2):273-9. PubMed ID: 22263396
[TBL] [Abstract][Full Text] [Related]
16. Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw.
Rotaru H; Kim MK; Kim SG; Park YW
J Oral Maxillofac Surg; 2015 Mar; 73(3):437-42. PubMed ID: 25544302
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
Maurer P; Sandulescu T; Kriwalsky MS; Rashad A; Hollstein S; Stricker I; Hölzle F; Kunkel M
Int J Oral Maxillofac Surg; 2011 Mar; 40(3):285-91. PubMed ID: 21163624
[TBL] [Abstract][Full Text] [Related]
18. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
Freiberger JJ; Padilla-Burgos R; McGraw T; Suliman HB; Kraft KH; Stolp BW; Moon RE; Piantadosi CA
J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292
[TBL] [Abstract][Full Text] [Related]
19. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
Chiu CT; Chiang WF; Chuang CY; Chang SW
J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
[TBL] [Abstract][Full Text] [Related]
20. The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla.
Gallego L; Junquera L; Pelaz A; Hernando J; Megías J
Med Oral Patol Oral Cir Bucal; 2012 Mar; 17(2):e236-41. PubMed ID: 22143692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]